$45,000 of ALIGNMENT HEALTHCARE INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medicare Advantage"
You can find more data on corporate lobbying on Quiver Quantitative.
ALHC Insider Trading Activity
ALHC insiders have traded $ALHC stock on the open market 83 times in the past 6 months. Of those trades, 0 have been purchases and 83 have been sales.
Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
- JOHN E KAO (Chief Executive Officer) has made 0 purchases and 15 sales selling 1,243,901 shares for an estimated $18,188,757.
- ROBERT THOMAS FREEMAN (Chief Financial Officer) has made 0 purchases and 13 sales selling 655,978 shares for an estimated $9,777,462.
- DAWN CHRISTINE MARONEY (President) has made 0 purchases and 13 sales selling 540,961 shares for an estimated $7,983,737.
- HAKAN KARDES (Chief Experience Officer) has made 0 purchases and 12 sales selling 215,342 shares for an estimated $3,232,356.
- HYONG KIM (Chief Medical Officer) has made 0 purchases and 9 sales selling 162,628 shares for an estimated $2,261,074.
- CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 6 sales selling 78,612 shares for an estimated $1,314,336.
- ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 7 sales selling 74,737 shares for an estimated $1,178,518.
- ANDREAS P. WAGNER (Chief Human Resources Officer) has made 0 purchases and 4 sales selling 27,398 shares for an estimated $421,679.
- SEBASTIAN BURZACCHI (COO - Mgmt Services Org) has made 0 purchases and 3 sales selling 15,244 shares for an estimated $206,061.
- JOSEPH S KONOWIECKI sold 6,920 shares for an estimated $95,011
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ALHC Hedge Fund Activity
We have seen 104 institutional investors add shares of ALHC stock to their portfolio, and 48 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WARBURG PINCUS LLC removed 13,622,779 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $153,256,263
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 3,550,683 shares (-32.7%) from their portfolio in Q4 2024, for an estimated $39,945,183
- WELLINGTON MANAGEMENT GROUP LLP added 3,257,630 shares (+77.9%) to their portfolio in Q4 2024, for an estimated $36,648,337
- CITADEL ADVISORS LLC added 3,088,765 shares (+inf%) to their portfolio in Q4 2024, for an estimated $34,748,606
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,059,596 shares (+54.7%) to their portfolio in Q4 2024, for an estimated $34,420,455
- MILLENNIUM MANAGEMENT LLC added 2,896,311 shares (+588.3%) to their portfolio in Q4 2024, for an estimated $32,583,498
- POINT72 ASSET MANAGEMENT, L.P. added 1,785,480 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,086,650
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ALHC Analyst Ratings
Wall Street analysts have issued reports on $ALHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 03/04/2025
- Cowen & Co. issued a "Buy" rating on 10/31/2024
- Barclays issued a "Underweight" rating on 10/30/2024
To track analyst ratings and price targets for ALHC, check out Quiver Quantitative's $ALHC forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
